Sitagliptin Hcs

Sitagliptin Hcs is an oral diabetes medication that helps control blood sugar levels. It belongs to the DPP-4 inhibitor class and is used alongside diet and exercise. This EU-manufactured treatment supports metabolic health for type 2 diabetes management.

Sitagliptin Hcs is used to improve blood sugar control in adults with type 2 diabetes. It works by increasing incretin hormones, which help regulate insulin release after meals. This medication is typically prescribed when diet and exercise alone are insufficient. It may be used alone or combined with other diabetes treatments.

Sitagliptin Hcs helps maintain steady blood sugar levels throughout the day. Users may experience more consistent energy levels and reduced sugar cravings. Some report improved overall well-being when combined with lifestyle adjustments. Individual responses may vary based on diet and activity levels.

Store Sitagliptin Hcs at room temperature away from moisture and heat. Keep out of reach of children and pets. Inform your healthcare provider about all medications you take before starting this treatment. Regular blood sugar monitoring is recommended during use.

Sitagliptin Hcs may interact with other diabetes medications, increasing the risk of low blood sugar. Alcohol consumption can affect blood sugar levels and may interact unpredictably with this medication. Certain medications like insulin or sulfonylureas may require dose adjustments when combined with Sitagliptin Hcs.